Germline Nonsense Mutation and Somatic Inactivation of SMARCA4/BRG1 in a Family with Rhabdoid Tumor Predisposition Syndrome

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg, Germany.
The American Journal of Human Genetics (Impact Factor: 10.99). 02/2010; 86(2):279-84. DOI: 10.1016/j.ajhg.2010.01.013
Source: PubMed

ABSTRACT Rhabdoid tumors of early infancy are highly aggressive with consequent poor prognosis. Most cases show inactivation of the SMARCB1 (also known as INI1 and hSNF5) tumor suppressor, a core member of the ATP-dependent SWI/SNF chromatin-remodeling complex. Familial cases, described as rhabdoid tumor predisposition syndrome (RTPS), have been linked to heterozygous SMARCB1 germline mutations. We identified inactivation of another member of the SWI/SNF chromatin-remodeling complex, its ATPase subunit SMARCA4 (also known as BRG1), due to a SMARCA4/BRG1 germline mutation and loss of heterozygosity by uniparental disomy in the tumor cells of two sisters with rhabdoid tumors lacking SMARCB1 mutations. SMARCA4 is thus a second member of the SWI/SNF complex involved in cancer predisposition. Its general involvement in other tumor entities remains to be established.

Download full-text


Available from: Markus Kreuz, Aug 14, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Information retrieval (IR) functions serve a critical role in many information systems. There are many techniques and operations have been developed in IR that do not require radical changes or re-implementation. The implemented IR algorithms can be distributed or their functions made available through the framework of web services. A key idea behind web services is that frequently used functions can be implemented once and offered to other application or software environments through programmatic interfaces. Web services in the IR domain have not been widely tested. Library of User-Oriented Concepts for Access Services (LUCAS) offers IR functions such as term extraction, term clustering, and document classification as web services. It has successfully served other information systems such as the Biological Knowledge through Ontologies (BioKnOT) and the Extensible Networked Association-based Bioinformatics Learning Environment (ENABLE) Knowledge Base. In this paper, we demonstrate the utility of LUCAS to the ENALBE system.
    Proceedings of the American Society for Information Science and Technology 01/2006; 42(1):n/a - n/a. DOI:10.1002/meet.14504201266
  • [Show abstract] [Hide abstract]
    ABSTRACT: Tremendous progress has recently been made in both molecular subgrouping, and the establishment of prognostic biomarkers for embryonal brain tumors, particularly medulloblastoma. Several prognostic biomarkers that were initially identified in retrospective cohorts of medulloblastoma, including MYC and MYCN amplification, nuclear β-catenin accumulation, and chromosome 17 aberrations have now been validated in clinical trials. Moreover, molecular subgroups based on distinct transcriptome profiles have been consistently reported from various groups on different platforms demonstrating that the concept of distinct medulloblastoma subgroups is very robust. Well-described subgroups of medulloblastomas include tumors showing wingless signaling pathway (Wnt) activation, and another characterized by sonic hedgehog pathway activity. Two or more additional subgroups were consistently reported to contain the vast majority of high-risk tumors, including most tumors with metastatic disease at diagnosis and/or large cell/anaplastic histology. Several years ago, atypical teratoid rhabdoid tumor (AT/RT) was recognized as a separate entity based on its distinct biology and particularly aggressive clinical behavior. These tumors may occur supra or infratentorially and are usually found to have genetic alterations of SMARCB1 (INI1/hSNF5), a tumor suppressor gene located on chromosome 22q. Subsequent loss of SMARCB1 protein expression comprises a relatively specific and sensitive diagnostic marker for AT/RT. For CNS primitive neuroectodermal tumors (CNS PNETs), a consistent finding has been that they are molecularly distinct from medulloblastoma. Furthermore, a distinct fraction of CNS PNETs with particularly poor prognosis only occurring in young children was delineated, which was previously labeled ependymoblastoma or embryonal tumor with abundant neuropil and true rosettes (ETANTR) and which is morphologically characterized by the presence of multilayered "ependymoblastic" rosettes. This group of tumors shows a unique cytogenetic abnormality not seen in other brain tumors: focal amplification of a micro-RNA cluster at chromosome 19q13.42, which has never been found to be amplified in other CNS PNETs, medulloblastoma or AT/RT. In summary, these consistent findings have significantly contributed to our ability to sub-classify embryonal brain tumors into clinically and biologically meaningful strata and, for some of the subgroups, have led to the identification of specific targets for future development of molecularly targeted therapies.
    Acta Neuropathologica 09/2010; 120(5):553-66. DOI:10.1007/s00401-010-0751-5 · 10.76 Impact Factor
  • Journal of Clinical Oncology 11/2010; 28(33):e688-91. DOI:10.1200/JCO.2010.29.9735 · 18.43 Impact Factor
Show more